Globe Life (GL) vs. The Competition Head-To-Head Comparison

Globe Life (NYSE: GL) is one of 40 public companies in the “Life insurance” industry, but how does it contrast to its rivals? We will compare Globe Life to related companies based on the strength of its profitability, dividends, valuation, risk, earnings, institutional ownership and analyst recommendations.

Valuation & Earnings

This table compares Globe Life and its rivals gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Globe Life $4.30 billion $701.47 million 15.39
Globe Life Competitors $18.20 billion $1.03 billion 12.60

Globe Life’s rivals have higher revenue and earnings than Globe Life. Globe Life is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.


This table compares Globe Life and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Globe Life 16.26% 12.34% 3.06%
Globe Life Competitors 8.49% 8.39% 1.00%


Globe Life pays an annual dividend of $0.69 per share and has a dividend yield of 0.7%. Globe Life pays out 11.3% of its earnings in the form of a dividend. As a group, “Life insurance” companies pay a dividend yield of 1.9% and pay out 18.4% of their earnings in the form of a dividend.

Institutional & Insider Ownership

75.6% of Globe Life shares are owned by institutional investors. Comparatively, 57.9% of shares of all “Life insurance” companies are owned by institutional investors. 3.6% of Globe Life shares are owned by insiders. Comparatively, 10.1% of shares of all “Life insurance” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Risk & Volatility

Globe Life has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500. Comparatively, Globe Life’s rivals have a beta of 0.93, suggesting that their average share price is 7% less volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings and target prices for Globe Life and its rivals, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Globe Life 0 0 1 0 3.00
Globe Life Competitors 541 1543 1791 104 2.37

Globe Life presently has a consensus price target of $114.00, indicating a potential upside of 20.87%. As a group, “Life insurance” companies have a potential upside of 19.98%. Given Globe Life’s stronger consensus rating and higher possible upside, equities analysts clearly believe Globe Life is more favorable than its rivals.


Globe Life beats its rivals on 10 of the 15 factors compared.

Globe Life Company Profile

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers term life, whole life, children's life, senior life, and family life insurance products; accidental benefits insurance; mortgage protection insurance; and medicare supplement plans. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. is based in McKinney, Texas.

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with's FREE daily email newsletter.